RISKS OF OVULATION-INDUCTION THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
D. Lê Thi Huong(Sorbonne Université), P Godeau(Normandie Université), Claude Gallinari(Sorbonne Université), Y Darbois(Sorbonne Université), S. Arfi, J.C. Piette(Sorbonne Université), B. Wechsler(King's College London), C. Françès(Navarre Institute of Health Research)
Cited by 46
Related Papers
Pacemaker infective endocarditis
|The American Journal of Cardiology|1998|314
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
|Lara D. Veeken|2007|301
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235